CClinicalTrials.gg
CompletedNCT04243174mHealthUpdated Aug 27, 2021

The Use of Short SMS Messaging With Type 2 Diabetes (T2DM)

An interventional study of SMS Messaging in Type 2 Diabetes and Physical Exercise, sponsored by University of Nottingham. Completed at 1 site in Saudi Arabia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-08-27.

Sponsored by University of Nottingham · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
57
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Physical activity (PA) can play a vital and an independent role in type 2 diabetes (T2DM) management care. Health research studies have shown evidence that PA can improve glycaemic control and glucose levels. PA is first line of self-care management recommended to patients with T2DM and most patients fail to perform the regular PA. It is always important for health providers to find better methods in encouraging and incentivizing PA in T2DM patients. Mobile phone messaging-based interventions have been shown to strengthen the delivery of health information and self-care management programs.

Read the detailed description

Studies have employed this as a tool for promoting T2DM self-care management interventions such as physical activity, glucose monitoring, medication adherence and nutrition. Despite the increasing number of these interventions globally, the effectiveness of mobile phone messaging-based interventions in Saudi Arabia context remains inconclusive and inconsistent. There is limited research conducted in this region. Therefore, there is a need for more studies to show evidence to ascertain the effectiveness of using mobile phone messaging to promote PA in T2DM patients in the context of Saudi Arabia.

02

Conditions studied

  • Type 2 Diabetes
  • Physical Exercise
03

In context

Diabetes Mellitus, Type 2

9,359 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,318 are open to participants now.

This study's enrollment of 57 is below the median of 80 across 7,525 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

University of Nottingham is the lead sponsor of 455 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinician diagnosis of T2DM.
  • Over 18 years of age.
  • Possession of a cell phone with text messaging capability.
  • Ability to read and understand Arabic.

Exclusion criteria

Exclusion Criteria:

  • Treatment with insulin adjustment
  • Unable to understand the study requirements or give informed consent.
  • Visual impairment.
  • Any diabetes-related complications such as neuropathy or retinopathy that preclude ability to increase PA.
  • Clinician concern (physicians will be asked to confirm whether eligible participants can be medically capable of performing PA at the recommended level advised by National Institute for Health and Care Excellence (NICE, 2013).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
57 participants (actual)

Study arms

  • Other
    SMS Messages

    Patients with type 2 diabetes will be recruited and will start receiving short SMS messages about physical activity, encouraging them to be more active and help them to build a healthy life style routine.

    Behavioral: SMS Messaging

Interventions

  • BehavioralSMS Messaging

    Patients with type 2 diabetes will be recruited and will start receiving short SMS messages about physical activity, encouraging them to be more active and help them to build a healthy life style routine.

06

What researchers measure

Primary outcomes

  1. Feasibility of mobile phone text messaging intervention for people with T2DM: Number of Participants recruited, completed the study, dropped out

    Number of Participants recruited, completed the study, dropped out.

    Time frame: Six weeks

Secondary outcomes

  1. Acceptability of mobile phone text messaging intervention for people with T2DM: Qualitative interviews

    Qualitative interviews will be undertaken with study participants and healthcare professionals (HCPs) to explore: satisfaction with the intervention; barriers and facilitators of the intervention; perceived impact of the intervention, and potential changes and necessary improvements.

    Time frame: Six weeks

  2. Clinical measurements pre and after the intervention

    Is glycated haemoglobin (HbA1c) sensitive to change when using SMS text messaging for physical activity promotion in the care of T2DM

    Time frame: 3 months

  3. Clinical measurements pre and after the intervention

    Is the body mass index (BMI) in kg/m\^2 sensitive to change when using SMS text messaging for physical activity promotion in the care of T2DM

    Time frame: 3 months

  4. Behaviour change outcome

    Is self-efficacy for physical activity (SEPA) questionnaire sensitive to change when using SMS text messaging for physical activity promotion in the care of T2DM. The total score is calculated by finding the sum of the all items. The total score ranges between 10 and 40, with a higher score indicating more self-efficacy.

    Time frame: Six weeks

  5. Self-report questionnaire (International Physical Activity Questionnaire - IPAQ)

    To compare levels of physical activity (PA) before and after an intervention, IPAQ is used to assess moderate-to-vigorous physical activity in adult people. Categorical Score- three levels of physical activity are proposed: 1. Low • No activity is reported. 2. Moderate * More days of vigorous activity of at least 20 minutes per day. 3. High * Vigorous-intensity activity on at least 3 days and accumulating at least 1500MET-minutes/week.

    Time frame: Six weeks

07

Study locations

1 site
  • King Fahd Medical City
    Riyadh, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: Yes — After the study has been conducted and completed.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04243174
Lead sponsor
University of Nottingham
Responsible party
Holly Blake (Associate Professor, University of Nottingham) — Principal investigator
First posted
Jan 28, 2020
Start date
Jan 23, 2020
Primary completion
Mar 1, 2020
Completion
Mar 30, 2020
Last update
Aug 27, 2021

Study contacts

Dr.Holly Blake, PhD
principal investigator · University of Nottingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion